ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
藥明合聯
41.150
-1.700
-3.97%
手動刷新
成交量:
1,177.16萬
成交額:
4.82億
市值:
494.21億
市盈率:
43.27
高:
42.550
開:
41.600
低:
39.650
收:
42.850
資料載入中...
總覽
公司
新聞
公告
里昂:首予藥明合聯“跑贏大市”評級 目標價44.3港元
新浪港股
·
02-28
里昂:首予藥明合聯(02268)“跑贏大市”評級 目標價44.3港元
智通财经
·
02-28
藥明合聯盤中異動 大幅下挫5.12%報32.450港元
市场透视
·
02-28
《大行》里昂首次覆蓋藥明合聯(02268.HK) 評級“跑贏大市” 目標價44.3元
阿斯达克财经
·
02-28
藥明合聯盤中異動 早盤股價大漲5.07%報36.250港元
市场透视
·
02-27
港股異動 | 藥明合聯(02268)午前漲超3% 宣佈與LigaChem Biosciences簽署合作備忘錄
智通财经
·
02-26
藥明合聯與LigaChem Biosciences簽署合作備忘錄,加速ADC開發
美通社
·
02-25
港股收評:恒指收跌0.58% 內房、內險股逆市拉昇
美港电讯
·
02-24
藥明合聯02月24日獲主力加倉1868萬元
市场透视
·
02-24
特朗普風險擾動市場?醫藥股突變,藥明系全線崩了!
格隆汇
·
02-24
《股市簡訊》“藥明系”港股全系大跌,美國擬進一步限制對生物技術等領域投資
路透中文
·
02-24
藥明合聯盤中異動 大幅下挫7.04%報35.000港元
市场透视
·
02-24
格隆匯個股放量排行榜 | 2月23日
格隆汇
·
02-23
野村:維持藥明合聯“買入”評級 升目標價至42.5港元
新浪港股
·
02-20
野村:維持藥明合聯(02268)“買入”評級 升目標價至42.5港元
智通财经
·
02-20
招商證券:ADC研發熱潮推動外包需求激增 ADC CDMO市場需求旺盛
智通财经
·
02-20
《大行》野村升藥明合聯(02268.HK)目標價42.5元 評級“買入”
阿斯达克财经
·
02-20
藥明合聯2月19日獲南向資金加倉203.29萬股
市场透视
·
02-20
港股異動 | 藥明合聯(02268)漲近6%創歷史新高 ADC藥物研發火熱 公司賦能大量國產ADC出海
智通财经
·
02-19
藥明合聯盤中異動 快速上漲5.11%報35.000港元
市场透视
·
02-19
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02268/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"藥明合聯","latestPrice":41.15,"timestamp":1743667696033,"preClose":42.85,"halted":0,"volume":11771578,"delay":0,"floatShares":1201000000,"shares":1201000000,"eps":0.9509737374268233,"marketStatus":"休市中","change":-1.7,"latestTime":"04-03 16:08:16","open":41.6,"high":42.55,"low":39.65,"amount":482354622,"amplitude":0.067678,"askPrice":41.2,"askSize":500,"bidPrice":41.15,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":0.8843699452447776,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":42.85,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.5754415858536063,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1201000000,"roa":"7.19%","roe":"17.69%","lyrEps":0.950974,"volumeRatio":0.5754415858536063,"shares":1201000000,"dividePrice":0,"high":42.55,"amplitude":0.067678,"preClose":42.85,"low":39.65,"week52Low":14.08,"pbRate":"6.99","psRate":"11.45","week52High":49.5,"institutionHeld":0,"latestPrice":41.15,"committee":0.92,"eps":0.9509737374268233,"divideRate":0,"volume":11771578,"delay":0,"ttmEps":0.8843699452447776,"open":41.6,"prevYearClose":30.65,"prevWeekClose":45.7,"prevMonthClose":44.4,"prevQuarterClose":44.4,"fiveDayClose":44.5,"twentyDayClose":34.8,"sixtyDayClose":29.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514180853","title":"里昂:首予藥明合聯“跑贏大市”評級 目標價44.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180853","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514180853?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 15:01","pubTimestamp":1740726060,"startTime":"0","endTime":"0","summary":" 里昂发布研报称,首次覆盖药明合联,给予“跑赢大市”评级,目标价44.3港元。药明合联2023年市场份额为14.5%,预计2024至2026财年收入增长分别为85%、40%及32%,每股盈利预测复合年均增长率为34%,该行的预测较市场共识高39%至43%。据外部机构预测,该公司2022至2030年的全球抗体—药物复合物外包市场收入复合年均增长率预计达到28%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2025-02-28/doc-inemzitr0032822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268"],"gpt_icon":0},{"id":"2514836009","title":"里昂:首予藥明合聯(02268)“跑贏大市”評級 目標價44.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514836009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514836009?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 11:34","pubTimestamp":1740713695,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,里昂发布研报称,首次覆盖药明合联,给予“跑赢大市”评级,目标价44.3港元。药明合联2023年市场份额为14.5%,预计2024至2026财年收入增长分别为85%、40%及32%,每股盈利预测复合年均增长率为34%,该行的预测较市场共识高39%至43%。据外部机构预测,该公司2022至2030年的全球抗体—药物复合物外包市场收入复合年均增长率预计达到28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2514398870","title":"藥明合聯盤中異動 大幅下挫5.12%報32.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514398870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514398870?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 11:22","pubTimestamp":1740712972,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘11时22分,药明合联股票出现异动,股价快速下挫5.12%。截至发稿,该股报32.450港元/股,成交量129.764万股,换手率0.11%,振幅6.73%。资金方面,该股资金流入1216.84万港元,流出2549.94万港元。药明合联股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,迈博药业-B、帝王国际投资、奥星生命科技涨幅较大,振幅较大的相关个股有帝王国际投资、科笛-B、昭衍新药,振幅分别为23.08%、16.80%、13.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281122529895bc87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281122529895bc87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2514369522","title":"《大行》里昂首次覆蓋藥明合聯(02268.HK) 評級“跑贏大市” 目標價44.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369522","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514369522?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 09:29","pubTimestamp":1740706140,"startTime":"0","endTime":"0","summary":"里昂发表研报指,药明合联2023年的市场份额为14.5%。据外部机构预测,该公司2022至2030年的全球抗体—药物复合物外包市场收入复合年均增长率预计达到28%。该行首次覆盖药明合联H股,给予“跑赢大市”评级,目标价定于44.3元。该行亦预计,药明合联2024至2026财年收入增长将分别为85%、40%及32%;每股盈利预测复合年均增长率为34%,该行的预测较市场共识高39%至43%。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104108628_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104108628_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1421010/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2514819468","title":"藥明合聯盤中異動 早盤股價大漲5.07%報36.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514819468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514819468?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 09:45","pubTimestamp":1740620726,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时45分,药明合联股票出现波动,股价快速上涨5.07%。截至发稿,该股报36.250港元/股,成交量65.95万股,换手率0.05%,振幅5.94%。资金方面,该股资金流入1284.73万港元,流出768.867万港元。药明合联股票所在的生物技术行业中,整体跌幅为1.31%。其相关个股中,北海康成-B、科笛-B、永泰生物-B涨幅较大,振幅较大的相关个股有北海康成-B、永泰生物-B、帝王国际投资,振幅分别为58.68%、16.25%、15.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270945269631d8aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270945269631d8aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2514507620","title":"港股異動 | 藥明合聯(02268)午前漲超3% 宣佈與LigaChem Biosciences簽署合作備忘錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2514507620","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514507620?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 11:27","pubTimestamp":1740540444,"startTime":"0","endTime":"0","summary":"消息面上,2月25日,药明合联宣布与 LigaChem Biosciences签署合作备忘录。LigaChem Biosciences是开发抗体偶联药物疗法以攻克癌症及其他重大疾病的行业先锋,此次新协议的签署标志着双方合作进一步扩大,有助于加速下一代ADC疗法的研发进程。借助药明合联的尖端技术及深厚专业积累,LigaChem Biosciences将加快推进ADC候选药物从发现至开发阶段,确保各阶段流程更加顺畅高效。此外,LigaChem Biosciences还将利用药明合联一体化ADC药物开发与生产平台,为多个ADC项目提供有力支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 药明合联(02268)午前涨超3% 宣布与LigaChem Biosciences签署合作备忘录","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","BK1141","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2514018325","title":"藥明合聯與LigaChem Biosciences簽署合作備忘錄,加速ADC開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018325","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514018325?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 18:25","pubTimestamp":1740479100,"startTime":"0","endTime":"0","summary":"LigaChem Biosciences是开发抗体偶联药物疗法以攻克癌症及其他重大疾病的行业先锋,此次新协议的签署标志着双方合作进一步扩大,有助于加速下一代ADC疗法的研发进程。根据合作备忘录,药明合联一体化ADC药物发现平台将助力LigaChem Biosciences大幅提升其ADC研发项目的速度与效率。关于 LigaChem Biosciences LigaChem Biosciences致力于发现和开发抗体偶联药物治疗癌症和其他严重疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4626686_ZH26686_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ADC","LU2488822045.USD","SG9999014674.SGD","02268","BK1141","BK4080","BK4231"],"gpt_icon":0},{"id":"2513714695","title":"港股收評:恒指收跌0.58% 內房、內險股逆市拉昇","url":"https://stock-news.laohu8.com/highlight/detail?id=2513714695","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513714695?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 16:17","pubTimestamp":1740385050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02359","09880","00960","399441","02269","HK0000320223.HKD","06060","LU1282651048.USD","TCEHY","00700","LU0828238088.HKD","000061","513600","02268","159715","80700","81024","LU0348814723.USD","LU0873338254.USD","SG9999000418.SGD","YANG","00241","LU1152091754.HKD","LU0577902298.EUR","HSTECH","IE00B97KM107.HKD","603259","TME","LU0348816934.USD","01698","HSI","HTCD.SI","LU0173614495.USD","LU0320764599.SGD","HSCEI","07226","01024","IE0008368411.USD","02833","LU0132412106.USD","HSImain","161726","HHImain","MCHmain","LU0823413660.USD","01209","IE00BYTNYN87.SGD","09660","MHImain"],"gpt_icon":1},{"id":"2513144117","title":"藥明合聯02月24日獲主力加倉1868萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513144117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513144117?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 16:15","pubTimestamp":1740384929,"startTime":"0","endTime":"0","summary":"02月24日, 药明合联股价跌9.56%,报收34.05元,成交金额4.82亿元,换手率1.18%,振幅12.08%,量比2.36。药明合联今日主力资金净流入1868万元,上一交易日主力净流入57万元。该股近5个交易日上涨7.52%,主力资金累计净流入2643万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入4737万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224161541a251a0e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224161541a251a0e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2513900057","title":"特朗普風險擾動市場?醫藥股突變,藥明系全線崩了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2513900057","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513900057?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 14:00","pubTimestamp":1740376853,"startTime":"0","endTime":"0","summary":"博弈","market":"hk","thumbnail":"https://img3.gelonghui.com/9a6cc-1ffa1029-e710-4191-a67b-4759b5812a33.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9a6cc-1ffa1029-e710-4191-a67b-4759b5812a33.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1801586","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["603259","02359","LU0348825331.USD","LU1242518857.USD","LU0819121731.USD","LU1242518931.SGD","BK1141","BK1574","LU2045819591.USD","LU1880383366.USD","BK1576","LU1794554557.SGD","LU0979878070.USD","LU0456846285.SGD","BK0216","BK1521","LU0456827905.SGD","LU0856984785.SGD","LU0043850808.USD","LU0708995583.HKD","LU1997245177.USD","LU1720050803.USD","LU2039709279.SGD","LU0359202008.SGD","02269","BK1610","BK1515","LU0516423091.SGD","LU0823426480.USD","LU1688375341.USD","LU0039217434.USD","LU0181495838.USD","LU0051755006.USD","LU0417516902.SGD","02268","BK1589","LU0516422366.SGD","SG9999002562.SGD","LU0823426308.USD","LU0417516738.SGD","BK1583","LU0456842615.SGD","IE00B0JY6N72.USD","LU2125910500.SGD","LU1046422090.SGD","LU0516423174.USD","LU0516422952.EUR","SG9999002463.SGD","LU1997245094.SGD","09939"],"gpt_icon":1},{"id":"2513791429","title":"《股市簡訊》“藥明系”港股全系大跌,美國擬進一步限制對生物技術等領域投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2513791429","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513791429?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 11:56","pubTimestamp":1740369376,"startTime":"0","endTime":"0","summary":"《股市简讯》“药明系”港股全系大跌,美国拟进一步限制对生物技术等领域投资* 在香港上市的中国“药明系”公司周一全系大跌,此前美国发布“美国优先”投资备忘录,拟进一步限制美国在生物技术等敏感领域的投资限制。白宫官员表示,特朗普政府将考虑对美国在敏感技术领域对中国的对外投资实施新的或扩大的限制,这些领域包括半导体、人工智能、量子、生物技术、航空航天等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3T3PF07Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","BK1521","LU0516422366.SGD","LU0823426308.USD","LU0043850808.USD","BK0216","BK1589","LU0140636845.USD","LU0979878070.USD","SG9999002463.SGD","SG9999002562.SGD","LU0320764599.SGD","BK1583","LU1997245177.USD","LU0039217434.USD","LU0417516902.SGD","LU0572944931.SGD","BK1576","BK1610","LU1046422090.SGD","LU1242518857.USD","LU2125910500.SGD","LU0307460666.USD","LU0051755006.USD","02268","603259","LU0456842615.SGD","LU0516422952.EUR","LU0326950275.SGD","02359","LU1720050803.USD","02269","LU0052750758.USD","SG9999014674.SGD","LU0516422440.USD","LU0181495838.USD","LU1880383366.USD","LU2045819591.USD","LU1997245094.SGD","BK1141","LU0516423174.USD","LU0819121731.USD","LU2488822045.USD","LU0456827905.SGD","LU0856984785.SGD","LU0327786744.USD","LU1242518931.SGD","LU0417516738.SGD","LU0359201612.USD","LU0348825331.USD"],"gpt_icon":1},{"id":"2513798120","title":"藥明合聯盤中異動 大幅下挫7.04%報35.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513798120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513798120?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:30","pubTimestamp":1740360628,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时30分,药明合联股票出现异动,股价大幅下挫7.04%。截至发稿,该股报35.000港元/股,成交量15.6万股,换手率0.01%,振幅5.31%。资金方面,该股资金流入14.02万港元,流出342.892万港元。药明合联股票所在的生物技术行业中,整体跌幅为1.41%。其相关个股中,创胜集团-B、君实生物、云顶新耀-B涨幅较大,振幅较大的相关个股有晶泰控股-P、加科思-B、药明生物,振幅分别为6.02%、4.57%、4.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093028abda3446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093028abda3446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2513739837","title":"格隆匯個股放量排行榜 | 2月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2513739837","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513739837?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 17:30","pubTimestamp":1740303003,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,上一交易日中创新航(03931)、开拓药业-B(09939)、首程控股(00697)、飞天云动(06610)、中国环境资源(01130)、先声药业(02096)、三叶草生物-B(02197)、药明康德(02359)、华润医疗(01515)、康龙化成(03759)、京信通信(02342)、山高控股(00412)、亚信科技(01675)、恒基地产(00012)、中国联通(0076","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23173048332183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02246","06881","02268","00340","06908","03698","02440","03382","02878","06616","01675","02410","00762","02567","02560","00013","06680","01696","00302","01349","01665","02556","01268","00839","01769","09959","02105","00547","00565","00144","00288","02678","02096","01815","00412","00363","01093","02126","00400","00696","00697","08071","03833","09885","02100","01616","00867","02339"],"gpt_icon":1},{"id":"2512223494","title":"野村:維持藥明合聯“買入”評級 升目標價至42.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512223494","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512223494?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 15:26","pubTimestamp":1740036360,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 野村发布研报称,维持对药明合联(02268)“买入”评级,目标价由34.11港元升至42.5港元。该行维持先前药明合联2024和2025财年预测,意味预期公司2024财年下半年营收与纯利同比增长分别为54%和255%。预测公司2025财年销售额同比增长50%,高于管理阶层在1月提出的35%指引。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:史丽君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-02-20/doc-inemchxc3817420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268"],"gpt_icon":0},{"id":"2512496772","title":"野村:維持藥明合聯(02268)“買入”評級 升目標價至42.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512496772","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512496772?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 14:28","pubTimestamp":1740032885,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,野村发布研报称,维持对药明合联(02268)“买入”评级,目标价由34.11港元升至42.5港元。该行维持先前药明合联2024和2025财年预测,意味预期公司2024财年下半年营收与纯利同比增长分别为54%和255%。预测公司2025财年销售额同比增长50%,高于管理阶层在1月提出的35%指引。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2512499896","title":"招商證券:ADC研發熱潮推動外包需求激增 ADC CDMO市場需求旺盛","url":"https://stock-news.laohu8.com/highlight/detail?id=2512499896","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512499896?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 14:27","pubTimestamp":1740032871,"startTime":"0","endTime":"0","summary":"同时,ADC研发热潮推动外包需求激增,ADC CDMO市场需求旺盛,当前市场呈现产能扩张与技术迭代双轮驱动格局。随着在研ADC药物逐步推进至商业化阶段,CDMO需求预计将持续增长,率先完成产能布局并得到相关项目验证的企业有望脱颖而出。2024年3月,公司与臻格生物签订战略合作协议,双方将联手为ADC药企提供从研发到生产的高效高品质一站式ADC CDMO服务平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","02268","BK0012","BK0188","06099","LU2488822045.USD","BK0276","BK1147","BK1564","600999","BK0183","SG9999014674.SGD","BK4139","CDMO","BK0028","ADC","BK0010","BK1141","BK4080"],"gpt_icon":0},{"id":"2512461490","title":"《大行》野村升藥明合聯(02268.HK)目標價42.5元 評級“買入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2512461490","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512461490?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 11:32","pubTimestamp":1740022320,"startTime":"0","endTime":"0","summary":"野村发表报告指,维持先前药明合联(02268.HK) 2024和2025财年预测,意味预期公司2024财年下半年营收与纯利按年增长分别为54%和255%。预测公司2025财年销售额按年增长50%,高于管理阶层在1月提出的35%指引。野村对该股目标价由34.11元升至42.5元。维持“买入”评级。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-19 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104104222_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1418764/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2512450969","title":"藥明合聯2月19日獲南向資金加倉203.29萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2512450969","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512450969?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 09:30","pubTimestamp":1740015024,"startTime":"0","endTime":"0","summary":"2月19日, 南向资金增持药明合联203.29万股。截止当日收盘,港股通共持有药明合联12398.58万股,占流通股10.31%。药明合联近5个交易日上涨20.47%,港股通累计增持187.18万股;近20个交易日上涨23.61%,港股通累计增持1235.58万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220093224a24c775f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220093224a24c775f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2512129196","title":"港股異動 | 藥明合聯(02268)漲近6%創歷史新高 ADC藥物研發火熱 公司賦能大量國產ADC出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2512129196","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512129196?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 14:32","pubTimestamp":1739946777,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,药明合联盘中涨近6%,高见35.25港元,创下历史新高。其中,药明合联全球份额第二,赋能大量国产ADC出海。2022年至2023年上半年,国内共有10家药企与海外合作伙伴达成14项ADC licsence out,其中有8家是药明合联的客户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","ADC","02268","SG9999014674.SGD","BK4231","BK4080","BK1141"],"gpt_icon":0},{"id":"2512025145","title":"藥明合聯盤中異動 快速上漲5.11%報35.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512025145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512025145?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 10:29","pubTimestamp":1739932180,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘10时29分,药明合联股票出现异动,股价快速上涨5.11%。截至发稿,该股报35.000港元/股,成交量204.7万股,换手率0.17%,振幅7.06%。资金方面,该股资金流入3900.59万港元,流出2435.61万港元。药明合联股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,华领医药-B、晶泰控股-P、腾盛博药-B涨幅较大,振幅较大的相关个股有华领医药-B、北海康成-B、晶泰控股-P,振幅分别为14.12%、12.50%、11.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021910294096282700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021910294096282700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","LU2488822045.USD","02268"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null},{"date":"2024-03-25","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.5556,"hold":0.0556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1743091200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2025-04-03","current":43.121995,"percent":0.439252,"low":0.407466,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"high":153.052589,"avg":46.164517,"sd":42.328118,"marketCap":49380552191},"quantilePoints":[{"date":"2020-04-09","current":0.444116,"twenty":2.759621,"median":7.82388,"eighty":11.01076,"marketCap":323186685},{"date":"2020-04-17","current":0.446187,"twenty":2.745207,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-04-24","current":0.446702,"twenty":2.734879,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-04-29","current":0.44639,"twenty":2.727395,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-05-08","current":0.446161,"twenty":2.71703,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-15","current":0.447931,"twenty":2.704934,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-22","current":0.449375,"twenty":2.687419,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-29","current":0.450088,"twenty":2.678738,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-05","current":0.44683,"twenty":2.666003,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-12","current":0.446873,"twenty":2.652949,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-19","current":0.446059,"twenty":2.62708,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-26","current":0.446464,"twenty":2.610591,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-03","current":0.445777,"twenty":2.573756,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-10","current":0.441566,"twenty":2.54079,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-17","current":0.440865,"twenty":2.474175,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-24","current":0.442598,"twenty":2.408815,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-31","current":0.440015,"twenty":2.351114,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-07","current":0.439541,"twenty":2.260124,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-14","current":0.438441,"twenty":0.452125,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-21","current":0.436461,"twenty":0.449515,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-28","current":0.43308,"twenty":0.448387,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-09-04","current":0.431618,"twenty":0.447817,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-11","current":0.431156,"twenty":0.447535,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-18","current":0.427016,"twenty":0.447373,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-25","current":0.430436,"twenty":0.447153,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-30","current":0.428392,"twenty":0.446995,"median":7.824737,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-09","current":0.422312,"twenty":0.446839,"median":7.815551,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-16","current":0.422486,"twenty":0.446689,"median":7.778238,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-23","current":0.421832,"twenty":0.446509,"median":7.763554,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-30","current":0.421767,"twenty":0.446296,"median":7.728277,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-06","current":0.416892,"twenty":0.446096,"median":7.681665,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-13","current":0.416542,"twenty":0.445828,"median":7.62168,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-20","current":0.413946,"twenty":0.445667,"median":7.588964,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-27","current":0.414916,"twenty":0.445574,"median":7.400318,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-04","current":0.411952,"twenty":0.44527,"median":7.31626,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-11","current":0.41294,"twenty":0.44498,"median":7.224146,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-18","current":0.412272,"twenty":0.444321,"median":7.177259,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-24","current":0.411847,"twenty":0.443892,"median":6.957959,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-31","current":0.411678,"twenty":0.44363,"median":6.764797,"eighty":11.047512,"marketCap":323186685},{"date":"2021-01-08","current":0.408416,"twenty":0.443491,"median":6.650061,"eighty":11.067383,"marketCap":323186685},{"date":"2021-01-15","current":0.408583,"twenty":0.442598,"median":6.55329,"eighty":11.072351,"marketCap":323186685},{"date":"2021-01-22","current":0.408755,"twenty":0.442234,"median":6.512372,"eighty":11.072351,"marketCap":323186685},{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191}],"updateTime":1743939899068}}}